Nintendo Switch 2 Dock Leak Hints at Faster Performance but 4K Output Reportedly Capped at 30 FPS 
Dr. Joseph Mercola Debunks Common Weightlifting Myths: What You Really Need to Know for Effective Strength Training 
Mark Zuckerberg and Elon Musk Challenge Sam Altman’s $157 Billion OpenAI Over Profit Ambitions 
Why Scottish salmon’s rebrand may end up harming the integrity of a top export and hurting producers 
Starbucks Baristas Kick Off Strikes in LA, Chicago, and Seattle as Holiday Pressure Mounts 
Canada's Response to Trump Tariffs Fuels Major Concern for Japan's Komatsu in Key Export Markets 
Nike Battles Sliding Revenue With Bold Plans for Premium Sales and Revamped Retail Strategy Under New CEO 
SK Hynix Wins $458M Funding to Power Indiana AI Chip Plant, Bolster US Semiconductor Sector 
NVIDIA Stock on Track for $170 by March: Mizuho Highlights Record AI Earnings as Key Driver 
Wall Street Jumps on Fed Rate Cut Hopes Driving Tesla and Nvidia Higher 
Economic Indicators from Auction Trends: What Car Auctions Reveal About Consumer Confidence 
How To Prepare for Global Economic Shifts in 2025? 
2025 Housing Market Outlook Brings Glimmers of Optimism but Affordability Concerns Still Loom Large 
Goldman Sachs Warns of Government Shutdown Risk as House Blocks Spending Package, Deadline Nears 
Fed Delivers Third Rate Cut but Doubles Down on Fewer Moves for 2025 
Nestlé revealed it will close two of its Health Science plants in the United States. The Swiss company explained that this move is a strategy to increase efficiency in its health nutrition business unit.
Nestlé Health Science is the company’s division that is focused on the research, development, and manufacturing of healthy and medical nutrition products. It is mainly known for its Nutren and Meritene brands. At any rate, it is said to be currently in the process of bringing together its supply chain network to boost efficiency.
The company issued a Worker Adjustment and Retraining Notification (WARN), and Nestlé Health Science’s director of project management and HR special projects, Chris Richardson, said in the memo that due to the closure of their two facilities, more than 300 employees are set to lose their jobs.
To be more exact, Richardson stated in the WARN that “312 positions will be eliminated on a permanent basis.” The two plants that would be shut down are those located in Findlay and Robinson Township, and the job cuts are expected to begin in late June.
“There are no bumping rights at the impacted facility. The employees have no elected collective bargaining representative,” the project management director added.
According to Penn Live News, Nestlé Health Sciences filed the WARN notice at the Pennsylvania Department of Industry. It was indicated in the memo that the company’s facilities at 600 Boyce Road, under the name of HVL LLC, and 112 Technology Drive in Pittsburgh, listed under the name Pure Encapsulations are set to cease operations.
The WARN Act is a government regulation that protects employees, communities, and even the families of workers in the U.S. This law provides protection by requiring companies and other employers to notify everyone if they are planning to close business. It is a must for this type of notice to be posted 60 days in advance.
